How would you treat a patient with newly diagnosed advanced urothelial cancer?
Would you treat with chemoimmunotherapy based on IMvigor130 data presented at ESMO Congress 2019?
Answer from: Medical Oncologist at Community Practice
The current standard of front line systemic therapy for advanced urothelial cancer is cisplatin based combination chemotherapy: cisplatin/gemcitabine or ddMVAC, for cisplatin eligible patients. For cisplatin ineligible patients, pembrolizumab (Keynote 052), atezolizumab (IMvigor 210) or ...
Comments
Medical Oncologist at University of Washington School of Medicine Agree with the above detailed answer by Dr. Paul. ...
Medical Oncologist at University of Washington School of Medicine P.S: Data from the Galsky et al. Hoosier trial was...
Agree with the above detailed answer by Dr. Paul. ...
P.S: Data from the Galsky et al. Hoosier trial was...